Chronic Exposure to Rifaximin Causes Hepatic Steatosis in Pregnane X Receptor-Humanized Mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic Exposure to Rifaximin Causes Hepatic Steatosis in Pregnane X Receptor-Humanized Mice
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 129, Issue 2, Pages 456-468
Publisher
Oxford University Press (OUP)
Online
2012-07-14
DOI
10.1093/toxsci/kfs211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
- (2012) Naoki Tanaka et al. HEPATOLOGY
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pregnane X receptor as a target for treatment of inflammatory bowel disorders
- (2012) Jie Cheng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Enteroendocrine cells and lipid absorption
- (2011) Georg Mellitzer et al. CURRENT OPINION IN LIPIDOLOGY
- Cytochrome P450s in the synthesis of cholesterol and bile acids - from mouse models to human diseases
- (2011) Gregor Lorbek et al. FEBS Journal
- Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis
- (2011) Georgios N. Kalambokis et al. HEPATOLOGY
- Molecular Mechanisms of Ezetimibe-Induced Attenuation of Postprandial Hypertriglyceridemia
- (2011) José C. Sandoval et al. Journal of Atherosclerosis and Thrombosis
- Deficiency of PXR decreases atherosclerosis in apoE-deficient mice
- (2011) Yipeng Sui et al. JOURNAL OF LIPID RESEARCH
- Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
- (2011) S. Huhulescu et al. JOURNAL OF MEDICAL MICROBIOLOGY
- CD36 as a lipid sensor
- (2011) Céline Martin et al. PHYSIOLOGY & BEHAVIOR
- Current and emerging drugs for the treatment of inflammatory bowel disease
- (2011) John Triantafillidis Drug Design Development and Therapy
- Pregnane X receptor- andCYP3A4-humanized mouse models and their applications
- (2010) Jie Cheng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile
- (2010) Marta Moya et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Triglycerides and gallstone formation
- (2010) A.H.M. Smelt CLINICA CHIMICA ACTA
- Triglyceride Level Affecting Shared Susceptibility Genes in Metabolic Syndrome and Coronary Artery Disease
- (2010) P. Kisfali et al. CURRENT MEDICINAL CHEMISTRY
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- Rifaximin intake leads to emergence of rifampin-resistant staphylococci
- (2010) Thomas Valentin et al. JOURNAL OF INFECTION
- Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation
- (2010) J. Cheng et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
- (2009) B. Viollet et al. Acta Physiologica
- As a Matter of Fat
- (2009) Rita T. Brookheart et al. Cell Metabolism
- Rifampicin-Activated Human Pregnane X Receptor and CYP3A4 Induction Enhance Acetaminophen-Induced Toxicity
- (2009) J. Cheng et al. DRUG METABOLISM AND DISPOSITION
- Rifaximin pharmacology and clinical implications
- (2009) Veronica Ojetti et al. Expert Opinion on Drug Metabolism & Toxicology
- Review of rifaximin as treatment for SIBO and IBS
- (2009) Mark Pimentel EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte
- (2009) Amélie Moreau et al. HEPATOLOGY
- Localization, function and regulation of the two intestinal fatty acid-binding protein types
- (2009) Emile Levy et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
- (2009) Menno Hoekstra et al. MOLECULAR PHARMACEUTICS
- The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease
- (2009) Silvia Sookoian et al. Pharmacogenetics and Genomics
- Rifaximin for Treatment of Hepatic Encephalopathy
- (2008) Darego O Maclayton et al. ANNALS OF PHARMACOTHERAPY
- Intestinally derived lipids: Metabolic regulation and consequences—An overview
- (2008) Katherine Cianflone et al. ATHEROSCLEROSIS SUPPLEMENTS
- Regulatory Cross-Talk between Drug Metabolism and Lipid Homeostasis: Constitutive Androstane Receptor and Pregnane X Receptor Increase Insig-1 Expression
- (2008) A. Roth et al. MOLECULAR PHARMACOLOGY
- PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics
- (2008) Bin Zhang et al. PHARMACOGENOMICS
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
- The current state of serum biomarkers of hepatotoxicity
- (2007) Josef Ozer et al. TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now